Ohad Amit

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

C.H. Compton, Jason Gubb, Richard Nieman et al. · The Lancet · 2001 · 210 citations

Translational Medicine, Selective Phosphodiesterase-4 Inhibitor, Medicine +5

Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease

Elizabeth Gamble, Diana C. Grootendorst, Christopher E. Brightling et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 209 citations

Antifibrotic Therapy, Inflammatory Lung Disease, Advanced Lung Disease +17

Cilomilast for COPD

Stephen I. Rennard, Neil Schachter, Mary E. Strek et al. · CHEST Journal · 2006 · 114 citations

Medicine, Pulmonary Medicine, Pulmonary Disease

Randomized study of pazopanib + lapatinib vs. lapatinib alone in patients with HER2-positive advanced or metastatic breast cancer

Dennis J. Slamon, Henry Gómez, Fairooz F. Kabbinavar et al. · Journal of Clinical Oncology · 2008 · 83 citations

Tumor Biology, Her2+ Breast Cancer, Metastatic Breast Cancer +12

Graphical approaches to the analysis of safety data from clinical trials

Ohad Amit, Richard M. Heiberger, P. W. Lane · Pharmaceutical Statistics · 2007 · 77 citations